Axsome Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $588.2M
Liabilities Breakdown FY2023
Total Liabilities: $397.3M
Asset Breakdown
Total Assets: $588.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $386.2M | 65.7% |
| Accounts Receivable | $94.8M | 16.1% |
| Inventory | $15.1M | 2.6% |
| Property, Plant & Equipment | $846.0K | 0.1% |
| Goodwill | $12.0M | 2.0% |
| Intangible Assets | $53.3M | 9.1% |
| Other Assets | $25.9M | 4.4% |
Liabilities Breakdown
Total Liabilities: $397.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $40.7M | 10.2% |
| Long-Term Debt | $178.1M | 44.8% |
| Other Liabilities | $178.5M | 44.9% |